Przegląd Epidemiologiczny - Państwowy Zakład Higieny

Nr 1Przewlekłe zakażenie HBV u chorych z zespołami proliferacyjnymi 3121. Holodniy M. Entecavir as prophylaxis against hepatitisB virus reactivation following chemotherapy forlymphoma. International Journal of Infectious Diseases2010; 14: e265–e266.22. Fujimoto K, Endo T, Nishio M, i in. Complete remissionof splenic marginal zone lymphoma after an acuteflare-up of hepatitis B in a hepatitis B virus carrier. Int JHematol 2009; 5: 601-604.23. Chung YL, Tsai TY. Promyelocytic Leukemia NuclearBodies Link the DNA Damage Repair Pathway withHepatitis B Virus Replication: Implications for HepatitisB Virus Exacerbation during Chemotherapy and Radiotherapy. Cancer Res 2009; 10: 1672-1685.24. Kojima H, Abei M, Takei N, i in. Fatal reactivation ofhepatitis B virus following cytotoxic chemotherapyfor acute myelogenous leukemia: fibrosing cholestatichepatitis. Eur J Haematol 2002; 69: 101–10425. Power JP, El Chaar M, Temple J, i in. HBV reactivationafter fludarabine chemotherapy identified on investigationof suspected transfusion-transmitted Hepatitis Bvirus. J Hepatol 2010; 4: 780-787.26. Orlando R, Tosone G, Tiseo D, i in. Severe Reactivationof Hepatitis B Virus Infection in a Patient with HairyCell Leukemia: Should Lamivudine Prophylaxis beRecommended to HBsAg-Negative, Anti-HBc-PositivePatients? Infection 2006; 34: 282–284.27. Wang F, Xu R, Luo H, i in. Clinical and prognosticanalysis of hepatitis B virus infection in diffuse largeB-cell lymphoma. BMC Cancer 2008; 8:115-126Otrzymano: 24.11.2011 r.Zaakceptowano do druku: 3.01.2012 r.Adres do korespondencji:Dr hab.med. Tadeusz Wojciech ŁapińskiKlinika Chorób Zakaźnych i HepatologiiUniwersytet Medyczny w Białymstoku15-540 Białystok, ul.Żurawia 14